Thrivent Financial for Lutherans Trims Stake in Chemed Corporation $CHE

Thrivent Financial for Lutherans cut its position in shares of Chemed Corporation (NYSE:CHE) by 96.3% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,348 shares of the company’s stock after selling 86,865 shares during the period. Thrivent Financial for Lutherans’ holdings in Chemed were worth $1,499,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Creekmur Asset Management LLC bought a new stake in shares of Chemed in the second quarter valued at about $28,000. First Horizon Corp bought a new stake in shares of Chemed in the 3rd quarter valued at about $31,000. Pilgrim Partners Asia Pte Ltd purchased a new stake in shares of Chemed in the 3rd quarter worth approximately $45,000. Parkside Financial Bank & Trust lifted its position in shares of Chemed by 86.3% in the 2nd quarter. Parkside Financial Bank & Trust now owns 95 shares of the company’s stock worth $46,000 after purchasing an additional 44 shares during the period. Finally, HM Payson & Co. boosted its stake in shares of Chemed by 35.5% during the third quarter. HM Payson & Co. now owns 103 shares of the company’s stock valued at $46,000 after purchasing an additional 27 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Chemed Stock Performance

Chemed stock opened at $463.71 on Friday. Chemed Corporation has a one year low of $408.42 and a one year high of $623.60. The stock has a market cap of $6.57 billion, a PE ratio of 24.52, a price-to-earnings-growth ratio of 2.25 and a beta of 0.44. The stock has a 50-day moving average of $438.84 and a two-hundred day moving average of $441.85.

Insider Buying and Selling

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction that occurred on Monday, November 24th. The shares were sold at an average price of $437.55, for a total transaction of $875,100.00. Following the sale, the chief executive officer owned 94,197 shares of the company’s stock, valued at approximately $41,215,897.35. The trade was a 2.08% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 3.29% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the company. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a report on Thursday, October 30th. Royal Bank Of Canada reduced their price target on Chemed from $589.00 to $572.00 and set an “outperform” rating for the company in a research report on Monday, November 10th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, January 21st. Finally, Jefferies Financial Group lowered Chemed from a “buy” rating to a “hold” rating in a research note on Thursday, January 22nd. Three analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $555.50.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.